Quest filed suit in the Central District of California seeking a declaratory judgment of invalidity and non-infringement for the following Myriad patents: U.S. Patent Nos. 5,654,155; 5,693,473; 5,709,999; 5,710,001; 5,747,282; 5,750,400; 5,753,441; 5,837,492; 6,033,857; 6,051,379; 6,083,698; 6,492,109; 6,951,721; and 7,250,497 (all of the patents asserted against Ambry Genetics and Gene-by-Gene as well as four additional ones indicated in bold).
Dagiti bambanag a katupag ti nagkauna a tabernakulo a nausar iti panagdaydayaw iti Dios—a pakairamanan ti lakasa ti tulag, simmarming a baybay, (palanggana a pagbugguan), dagiti pagsilawan, daton nga insienso, ken ti altar a pagidatonan.​—Exodo 25:10, 17, 18; 40:24-32; Apocalipsis 4:​5, 6; 5:8; 8:3; 11:19.